Related Experiment Video
Updated: Apr 14, 2026

Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Predictive value of elevated neutrophil-lymphocyte ratio for left ventricular systolic dysfunction in patients with
Adem Bekler1, Gokhan Erbag2, Hacer Sen3
1Adem Bekler, MD, Department of Cardiology, Canakkale Onsekiz Mart University, School of Medicine, Canakkale/Turkey.
Insights
A high neutrophil-lymphocyte ratio (NLR) predicts left ventricular systolic dysfunction (LVSD) in non ST-elevated acute coronary syndrome (NSTE-ACS) patients. Admission NLR >3.2 identifies high-risk individuals needing tailored treatment strategies.
Area of Science:
- Cardiology
- Hematology
- Biomarkers
Background:
- Non ST-elevated acute coronary syndrome (NSTE-ACS) is a common cardiac emergency.
- Left ventricular systolic dysfunction (LVSD) is a significant complication impacting patient outcomes.
- Identifying early predictors of LVSD in NSTE-ACS is crucial for timely intervention.
Purpose of the Study:
- To investigate the predictive value of the neutrophil-lymphocyte ratio (NLR) for LVSD in NSTE-ACS patients.
- To determine if admission NLR can identify patients at higher risk of developing LVSD.
Main Methods:
- A cohort of 405 NSTE-ACS patients was analyzed.
- Patients were stratified into tertiles based on admission NLR values (low ≤1.81, medium 1.81-3.2, high >3.2).
- Multivariate analyses were performed to identify independent predictors of systolic dysfunction.
Main Results:
- The high NLR group (NLR >3.2) exhibited older age, higher rates of diabetes and NSTEMI, and lower left ventricular ejection fraction (LVEF).
- NLR was negatively correlated with LVEF.
- An NLR >3.2 and age ≥70 were independent predictors of systolic dysfunction.
Conclusions:
- An admission NLR >3.2 is a valuable predictor of LVSD in NSTE-ACS patients.
- Utilizing NLR on admission can aid in identifying high-risk patients.
- This may guide the selection of appropriate treatment strategies for these patients.
Objective:
We aimed to study the predictive value of the neutrophil-lymphocyte ratio (NLR) for left ventricular systolic dysfunction (LVSD) in patients with non ST-elevated acute coronary syndrome (NST-ACS).
Methods:
A total of 405 patients (mean age 62 years and 75% male) with NST-ACS were included in the study. The study population was divided into tertiles based on admission NLR values. The low, medium and high tertiles defined as NLR≤1.81 (n=135), 1.81
Results:
The patients in the high NLR group were older (p<0.001), have higher rate of diabetes mellitus (p=0.028) and non-ST elevated myocardial infarction (NSTEMI) (p<0.001) and have lower left ventricular ejection fraction (LVEF) (p<0.001). Baseline WBC (p=0.02) and neutrophil (p<0.001) levels and NLR (p<0.001) were significantly higher, baseline hemoglobin (p=0.044), hematocrit (p=0.019) and lymphocyte (p<0.001) levels were significantly lower in the high NLR group. NLR was negatively correlated with LVEF in correlation analysis. An NLR >3.2 and age ≥70 were found to be an independent predictor of systolic dysfunction in multivariate analyses.
Conclusion:
An NLR >3.2 is a useful predictor for LVSD in patients with NST-ACS. The practice of using an NLR count on admission may be useful for identifying high-risk patients and their associated treatment methods.
More Related Videos
04:41Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
Published on: July 3, 2018
07:13Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
Published on: April 18, 2025
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations